Latest Ratios: P/E Ratio 17.6x · EV/EBITDA 11.8x · ROE 15.9%. (2005–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $104M | $162M | $161M | $94M | $79M | $78M | $25M | $15M | $936770 | $5M | $20M |
| Enterprise Value | $148M | $206M | $170M | $113M | $66M | $68M | $19M | $15M | $1M | $6M | $21M |
| P/E Ratio → | 17.59 | 25.83 | 17.96 | 17.69 | 17.92 | 14.55 | 2.77 | 6.04 | 2.32 | — | 47.60 |
| P/S Ratio | 1.28 | 1.99 | 2.50 | 1.78 | 2.76 | 2.80 | 1.11 | 0.79 | 0.05 | 0.28 | 0.78 |
| P/B Ratio | 2.53 | 3.72 | 4.47 | 3.47 | 3.71 | 4.50 | 2.07 | 4.60 | 0.40 | 5.54 | 1.87 |
| P/FCF | 14.07 | 21.94 | 16.81 | 22.77 | 19.22 | 17.43 | 4.29 | 6.80 | 3.63 | 10.50 | — |
| P/OCF | 13.99 | 21.82 | 16.79 | 22.20 | 19.22 | 17.43 | 4.29 | 6.80 | 3.63 | 7.58 | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.53 | 2.64 | 2.14 | 2.30 | 2.45 | 0.85 | 0.79 | 0.07 | 0.35 | 0.84 |
| EV / EBITDA | 11.76 | 16.40 | 12.88 | 14.74 | 11.48 | 10.87 | 4.31 | 5.84 | 1.63 | — | 22.38 |
| EV / EBIT | 12.17 | 20.41 | 12.87 | 14.04 | 11.37 | 10.97 | 4.35 | 5.77 | 1.80 | — | 44.55 |
| EV / FCF | — | 27.84 | 17.74 | 27.39 | 16.03 | 15.26 | 3.30 | 6.80 | 4.57 | 12.80 | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 38.6% | 38.6% | 43.6% | 40.7% | 41.8% | 44.8% | 43.1% | 41.3% | 39.5% | 28.6% | 39.8% |
| Operating Margin | 14.9% | 14.9% | 20.3% | 14.3% | 19.8% | 22.3% | 19.7% | 13.2% | 3.8% | -50.3% | 1.9% |
| Net Profit Margin | 7.8% | 7.8% | 13.9% | 10.0% | 15.4% | 19.4% | 39.9% | 13.8% | 3.0% | -54.8% | 1.5% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 15.9% | 15.9% | 28.4% | 21.9% | 22.9% | 37.0% | 116.0% | 95.4% | 31.6% | -170.6% | 3.6% |
| ROA | 7.7% | 7.7% | 15.8% | 13.1% | 18.8% | 28.4% | 76.9% | 44.3% | 8.0% | -87.1% | 2.2% |
| ROIC | 13.8% | 13.8% | 21.6% | 20.9% | 54.1% | 67.7% | 68.4% | 65.8% | 21.4% | -95.0% | 3.0% |
| ROCE | 18.4% | 18.4% | 28.4% | 22.7% | 29.3% | 41.6% | 54.2% | 88.0% | 40.5% | -151.6% | 4.3% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.04 | 1.04 | 0.37 | 0.75 | 0.00 | 0.01 | 0.06 | 0.08 | 0.22 | 2.59 | 0.27 |
| Debt / EBITDA | 3.60 | 3.60 | 1.02 | 2.64 | 0.02 | 0.03 | 0.15 | 0.10 | 0.69 | — | 3.03 |
| Net Debt / Equity | — | 1.00 | 0.25 | 0.70 | -0.62 | -0.56 | -0.48 | -0.00 | 0.10 | 1.21 | 0.15 |
| Net Debt / EBITDA | 3.47 | 3.47 | 0.68 | 2.49 | -2.28 | -1.55 | -1.29 | -0.00 | 0.33 | — | 1.67 |
| Debt / FCF | — | 5.89 | 0.94 | 4.62 | -3.19 | -2.17 | -0.99 | -0.00 | 0.93 | 2.29 | — |
| Interest Coverage | 5.42 | 5.42 | 9.68 | 7.83 | — | — | 289.73 | 56.68 | 4.91 | -79.91 | 4.36 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.53 | 1.53 | 1.60 | 1.42 | 5.43 | 4.36 | 2.84 | 2.05 | 1.53 | 1.06 | 1.75 |
| Quick Ratio | 0.54 | 0.54 | 0.62 | 0.54 | 3.30 | 2.75 | 1.99 | 0.97 | 0.54 | 0.58 | 0.94 |
| Cash Ratio | 0.08 | 0.08 | 0.40 | 0.11 | 3.11 | 2.44 | 1.53 | 0.10 | 0.07 | 0.21 | 0.28 |
| Asset Turnover | — | 0.77 | 1.10 | 0.95 | 1.12 | 1.30 | 1.33 | 3.08 | 2.91 | 2.59 | 1.63 |
| Inventory Turnover | 2.35 | 2.35 | 3.29 | 3.44 | 1.84 | 2.36 | 3.56 | 3.81 | 2.93 | 4.42 | 4.06 |
| Days Sales Outstanding | — | 39.27 | 9.35 | 21.23 | 8.93 | 12.36 | 29.66 | 44.29 | 40.16 | 40.25 | 37.90 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | 0.4% | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 5.7% | 3.9% | 5.6% | 5.7% | 5.6% | 6.9% | 36.0% | 16.6% | 43.1% | — | 2.1% |
| FCF Yield | 7.1% | 4.6% | 6.0% | 4.4% | 5.2% | 5.7% | 23.3% | 14.7% | 27.5% | 9.5% | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 1.0% | 0.6% | 0.7% | 11.0% | 0.0% | 0.0% | 0.8% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 1.0% | 0.6% | 0.7% | 11.4% | 0.0% | 0.0% | 0.8% |
| Shares Outstanding | — | $10M | $10M | $10M | $10M | $10M | $9M | $9M | $875486 | $8M | $8M |
Integration-driven margin dilution
Based on current market data, FTLF trades at a forward P/E of 13.12, which appears to discount the company's recent inorganic growth strategy and suggests investors are pricing in significant execution risk regarding the successful integration of newly acquired distressed brand assets into the existing portfolio.
The current valuation multiple sits below many high-growth consumer peers, implying that the market remains skeptical of the company's ability to sustain its recent revenue acceleration without further margin erosion. This pricing suggests that the market views FTLF as a turnaround platform rather than a high-quality compounder, necessitating consistent earnings beats to justify a multiple expansion.
According to reported financial statements, FTLF's ROIC has trended downward to 2.6% in 2026Q1 from a peak of 6.3% in 2024Q2, indicating that the company's aggressive acquisition-led growth strategy is currently failing to generate returns that exceed the cost of capital employed for these investments.
The compression in ROIC suggests that the capital deployed for recent brand acquisitions is not yet yielding the expected operational synergies. Investors should monitor whether this trend reverses as integration efforts mature, or if the company's reliance on inorganic expansion will continue to suppress long-term capital efficiency.
As reported in recent filings, the cash conversion cycle has expanded to 112 days in 2026Q1 from 64 days in 2024Q2, primarily driven by a significant increase in days inventory outstanding, which suggests potential inefficiencies in managing product turnover across the newly expanded brand portfolio.
The lengthening of the cash conversion cycle indicates that capital is increasingly trapped in inventory, which may be a byproduct of integrating distressed assets with slower sell-through rates. This trend warrants further investigation into whether the company is overstocking to support its DTC channel or if it is struggling with product obsolescence.
Based on FTLF's reported figures, the debt-to-equity ratio has climbed to 0.93 in 2026Q1, a sharp increase from 0.27 in 2025Q2, signaling that the company has significantly leveraged its balance sheet to fund its recent inorganic growth initiatives within the competitive nutritional supplement sector.
The rising debt burden, coupled with a declining interest coverage ratio of 4.16, suggests that the company's margin for error has narrowed considerably. This leverage profile increases the company's sensitivity to interest rate fluctuations and operational downturns, potentially limiting management's ability to pursue future strategic opportunities without further equity dilution.
The P/E ratio is frequently misapplied to FTLF, as it obscures the significant non-cash charges and integration costs associated with the company's serial acquisition model, which often artificially depress reported net income and provide a misleading view of the firm's underlying cash-generative potential.
Analysts should instead focus on EV/EBITDA or adjusted free cash flow metrics to better capture the operational performance of the brand portfolio. Relying on P/E ignores the reality that FTLF is currently in a capital-intensive integration phase where accounting earnings are less representative of true economic value creation.
Includes 30+ ratios · 21 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying FTLF stock.
FitLife Brands, Inc.'s current P/E ratio is 17.6x. The historical average is 18.3x. This places it at the 42th percentile of its historical range.
FitLife Brands, Inc.'s current EV/EBITDA is 11.8x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 14.5x.
FitLife Brands, Inc.'s return on equity (ROE) is 15.9%. The historical average is -21.9%.
Based on historical data, FitLife Brands, Inc. is trading at a P/E of 17.6x. This is at the 42th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
FitLife Brands, Inc. has 38.6% gross margin and 14.9% operating margin. Operating margin between 10-20% is typical for established companies.
FitLife Brands, Inc.'s Debt/EBITDA ratio is 3.6x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.